Julius Olugbenga Soyinka
5PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 28, 2022
Trough plasma nevirapine levels, immunologic and virologic responses in composite CYP2B6*6/*18 HIV-infected adult Nigerian patients.Sa'ad T Abdullahi, Julius O Soyinka, Rahman A Bolarinwa
|Nov 27, 2020
Effect of CYP3A5*3 genotypes on lumefantrine plasma concentrations among malaria-HIV-infected women.Adebanjo J Adegbola, Julius O Soyinka, Oluseye O Bolaji
|Oct 29, 2020
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy.Ayorinde Adehin, Martin Alexander Kennedy, Julius Olugbenga Soyinka
|Dec 25, 2019
Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by CYP2B6 c.516G>T Genotypes.Sa'ad T Abdullahi, Julius O Soyinka, Adeniyi Olagunju
|Sep 25, 2019
CYP2B6*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers.Sa'ad T Abdullahi, Julius O Soyinka, Adeniyi Olagunju
Pageof 1
Frequent Collaborators
1 joint publications
Adeniyi Olagunju
1 joint publications
Joel Tarning
1 joint publications
Saye Khoo
1 joint publications
Adebanjo J Adegbola
1 joint publications
Sa'ad T Abdullahi
1 joint publications
Rahman A Bolarinwa
1 joint publications
Martin Alexander Kennedy
1 joint publications
Olalekan Olasehinde
1 joint publications
Oluseye Oladotun Bolaji
